Nicole Barna files SEC Form 4 disclosures for Codiak BioSciences, Inc.. They have made 4 open-market trades across 1 company since 2022, most recently 2023-03-29.
CIK 0001828135
1 open-market purchase totalling $50K since 2022, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDAK | 4,849 | $276 |
Shares reported on the most recent Form 4, priced at the 2023-03-30 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.